214 related articles for article (PubMed ID: 16770319)
1. Kallidin-like peptide mediates the cardioprotective effect of the ACE inhibitor captopril against ischaemic reperfusion injury of rat heart.
Liu X; Lukasova M; Zubakova R; Lewicka S; Hilgenfeldt U
Br J Pharmacol; 2006 Jul; 148(6):825-32. PubMed ID: 16770319
[TBL] [Abstract][Full Text] [Related]
2. A kallidin-like peptide is a protective cardiac kinin, released by ischaemic preconditioning of rat heart.
Liu X; Lukasova M; Zubakova R; Lewicka S; Hilgenfeldt U
Br J Pharmacol; 2005 Dec; 146(7):952-7. PubMed ID: 16231012
[TBL] [Abstract][Full Text] [Related]
3. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
Hartman JC
Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
[TBL] [Abstract][Full Text] [Related]
4. Local inhibition of bradykinin degradation in ischemic hearts.
Linz W; Martorana PA; Schölkens BA
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
[TBL] [Abstract][Full Text] [Related]
5. [Mechanism of cardioprotection against ischemia/reperfusion injury by valsartan: an experiment with isolated rat hearts].
Zhang YJ; Bai XJ; Qi ZM; Wang HX
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3350-3. PubMed ID: 16409843
[TBL] [Abstract][Full Text] [Related]
6. Captopril potentiates the myocardial infarct size-limiting effect of ischemic preconditioning through bradykinin B2 receptor activation.
Miki T; Miura T; Ura N; Ogawa T; Suzuki K; Shimamoto K; Iimura O
J Am Coll Cardiol; 1996 Nov; 28(6):1616-22. PubMed ID: 8917279
[TBL] [Abstract][Full Text] [Related]
7. Compensatory function of bradykinin B1 receptor in the inhibitory effect of captopril on cardiomyocyte hypertrophy and cardiac fibroblast proliferation in neonatal rats.
Zou J; Ren JH; Feng D; Wang H; Xu J
Chin Med J (Engl); 2008 Jul; 121(13):1220-5. PubMed ID: 18710643
[TBL] [Abstract][Full Text] [Related]
8. [Cardioprotective effects of sodium ferulate mediated by nitric oxide on ischemia-reperfusion injured myocardium: experiment with isolated rat hearts].
Liu JC; Kang J; Shao LJ; He M
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):987-91. PubMed ID: 16759542
[TBL] [Abstract][Full Text] [Related]
9. Omapatrilat limits infarct size and lowers the threshold for induction of myocardial preconditioning through a bradykinin receptor-mediated mechanism.
Ebrahim Z; Baxter GF; Yellon DM
Cardiovasc Drugs Ther; 2004 Mar; 18(2):127-34. PubMed ID: 15162074
[TBL] [Abstract][Full Text] [Related]
10. Captopril reverses the reduced vasodilator response to bradykinin in hypertensive pregnant rats.
Resende AC; Pimentel AM; de Moura RS
Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):756-61. PubMed ID: 15566389
[TBL] [Abstract][Full Text] [Related]
11. [Cardioprotective effects by ramipril after ischemia and reperfusion in animal experiment studies].
Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
Z Kardiol; 1994; 83 Suppl 4():53-6. PubMed ID: 7856280
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotective effect of bradykinin-induced preconditioning mediated by calcitonin gene-related peptide in isolated rat heart.
Song QJ; Li YJ; Deng HW
Zhongguo Yao Li Xue Bao; 1999 Feb; 20(2):162-6. PubMed ID: 10437165
[TBL] [Abstract][Full Text] [Related]
13. Effect of desflurane-induced preconditioning following ischemia-reperfusion on nitric oxide release in rabbits.
Tsai SK; Lin SM; Huang CH; Hung WC; Chih CL; Huang SS
Life Sci; 2004 Dec; 76(6):651-60. PubMed ID: 15567190
[TBL] [Abstract][Full Text] [Related]
14. Acute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor mixanpril on insulin sensitivity in obese Zucker rat.
Arbin V; Claperon N; Fournié-Zaluski MC; Roques BP; Peyroux J
Br J Pharmacol; 2001 Jun; 133(4):495-502. PubMed ID: 11399666
[TBL] [Abstract][Full Text] [Related]
15. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Liu YN; Zhou ZM; Chen P
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
[TBL] [Abstract][Full Text] [Related]
16. Kallidin- and bradykinin-degrading pathways in human heart: degradation of kallidin by aminopeptidase M-like activity and bradykinin by neutral endopeptidase.
Kokkonen JO; Kuoppala A; Saarinen J; Lindstedt KA; Kovanen PT
Circulation; 1999 Apr; 99(15):1984-90. PubMed ID: 10209002
[TBL] [Abstract][Full Text] [Related]
17. [Role of B1 receptors in the endothelial protective effect of ischaemic preconditioning].
Bouchard JF; Chouinard J; Lamontagne D
Arch Mal Coeur Vaiss; 1998 Aug; 91(8):941-5. PubMed ID: 9749141
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia in mice.
Messadi-Laribi E; Griol-Charhbili V; Gaies E; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):489-93. PubMed ID: 18307747
[TBL] [Abstract][Full Text] [Related]
19. [ACE inhibition: mechanisms of "cardioprotection" in acute myocardial ischemia].
Schölkens BA; Linz W
Klin Wochenschr; 1991; 69 Suppl 24():1-5. PubMed ID: 1865630
[TBL] [Abstract][Full Text] [Related]
20. Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors.
Linz W; Schölkens BA
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S83-90. PubMed ID: 1282635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
